Literature DB >> 24754581

Novel approaches to the diagnosis and treatment of breast cancer.

Ismail Jatoi1, John R Benson.   

Abstract

36th San Antonio Breast Cancer Symposium, San Antonio, TX, USA, 10-14 December 2013 Progress in the treatment of breast cancer continues to require the thoughtful planning of new clinical trials and patient participation in those trials. During the 2013 San Antonio Breast Cancer Symposium (SABCS), the results of several clinical trials with practice-changing implications were presented. Additionally, the results of numerous interesting and provocative observational studies were reported. There were also several plenary lectures during the 2013 SABCS that addressed timely and controversial topics. The SABCS is a global forum for clinicians and scientists who are committed to eradicating the burden of breast cancer mortality worldwide. In this report, we highlight only a few of the many important studies and plenary talks presented during the 2013 SABCS.

Entities:  

Mesh:

Year:  2014        PMID: 24754581     DOI: 10.2217/fon.14.12

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  3 in total

Review 1.  Serum microRNA-21 as a potential diagnostic biomarker for breast cancer: a systematic review and meta-analysis.

Authors:  Shichao Li; Xiaorong Yang; Jinmei Yang; Jiesheng Zhen; Dechun Zhang
Journal:  Clin Exp Med       Date:  2014-12-17       Impact factor: 3.984

2.  Contralateral prophylactic mastectomy and its association with reduced mortality: evidence for selection bias.

Authors:  Ismail Jatoi; Helen M Parsons
Journal:  Breast Cancer Res Treat       Date:  2014-10-10       Impact factor: 4.872

3.  Long noncoding RNA LINC00899 suppresses breast cancer progression by inhibiting miR-425.

Authors:  Wenying Zhou; Jiao Gong; Yaqiong Chen; Jiahao Chen; Qi Zhuang; Jing Cao; Zhixiong Mei; Bo Hu
Journal:  Aging (Albany NY)       Date:  2019-11-18       Impact factor: 5.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.